AMIX — Autonomix Medical, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1617867 ·
Last close
$3.44
Market Cap
$1.87M
52W High
$8.88
52W Low
$2.44
ADV30
3,186,534
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -2,737,000 | -2,666,000 | 7,600,000 | 7,004,000 | 1,705,000 |
| Dec 2025 | 0 | — | -3,343,000 | -3,261,000 | 10,211,000 | 9,934,000 | 1,650,000 |
| Sep 2025 | 0 | — | -7,534,000 | -7,451,000 | 7,932,000 | 7,477,000 | 1,487,000 |
| Jun 2025 | 0 | — | -3,421,000 | -3,337,000 | 8,997,000 | 8,589,000 | 1,965,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-12,282,000
Investing CF
$-10,000
Financing CF
$10,160,000
CapEx
$-12,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-4.27
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-67,094,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-16,715,000
Pretax Income TTM
$-16,715,000
Interest Exp TTM
$0
Analysts
2
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | -17,034,000 | -16,715,000 | 7,600,000 | 1,705,000 | — | -12,282,000 |
| Mar 2025 | 0 | -11,588,000 | -11,410,000 | 9,806,000 | 1,707,000 | — | -8,258,000 |
| Mar 2024 | 0 | -7,474,000 | -15,426,000 | 9,407,000 | 1,779,000 | — | -6,648,000 |
| Mar 2023 | 0 | -1,990,000 | -1,990,000 | 865,000 | 221,000 | — | -1,854,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-7.40
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FEED | ENvue Medical, Inc. | $1.92M | $0.32 | — |
| AEMD | AETHLON MEDICAL INC | $1.75M | $0.66 | — |
| IVF | INVO Fertility, Inc. | $1.67M | $0.94 | — |
| BTCY | BIOTRICITY INC. | $2.21M | $0.11 | — |
| NUMD | Nu-Med Plus, Inc. | $1.54M | $0.02 | — |
News headlines (Yahoo Finance, 1h cache)
Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study
2026-07-24 12:47 · Yahoo
Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform
2026-07-23 11:30 · Yahoo
Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform
2026-07-15 12:00 · Yahoo
Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
2026-07-14 01:30 · Yahoo
Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant
2026-07-13 11:30 · Yahoo
Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change
2026-06-22 12:00 · Yahoo
Autonomix Announces Reverse Stock Split
2026-06-18 20:30 · Yahoo
Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine
2026-06-04 13:05 · Yahoo
Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation
2026-05-19 12:30 · Yahoo
Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
2026-05-18 12:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.